SEC Filings

Filing date Form Description View
4

Statement of changes in beneficial ownership of securities

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
3/A

An amendment to a 3 filing. Non-EDGAR filing

View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML

Data provided by Kaleidoscope.

 

 

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools